BIOMERICA INC Current Federal Tax Expense (Benefit)
BIOMERICA INC (BMRA) reported Current Federal Tax Expense (Benefit) of $83.00 thousand for the 12-month period ending 2012-05-31, per its 10-K filed 2012-08-29.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2012-08-29
- BIOMERICA INC current federal tax expense (benefit) for fiscal 2012 was $83.00K, a 9.21% increase from fiscal 2011.
- BIOMERICA INC current federal tax expense (benefit) for fiscal 2011 was $76.00K.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2012-05-31 | $83.00K 10-K · filed 2012-08-29 |
| 2011-05-31 | $76.00K 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |